We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$418M
AUM Growth
+$15.7M
Cap. Flow
+$2.3M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.42%
Holding
120
New
4
Increased
36
Reduced
38
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 15.41%
2 Consumer Staples 11.33%
3 Healthcare 11.05%
4 Financials 10.56%
5 Industrials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMC icon
51
Omnicom Group
OMC
$21.6B
$3.62M 0.86%
50,261
+335
+0.7% +$24.7K
COP icon
52
ConocoPhillips
COP
$147B
$3.55M 0.85%
39,552
+6,034
+18% +$543K
LLY icon
53
Eli Lilly
LLY
$1.02T
$3.26M 0.78%
4,188
HD icon
54
Home Depot
HD
$331B
$3.23M 0.77%
8,805
IJH icon
55
iShares Core S&P Mid-Cap ETF
IJH
$122B
$3.12M 0.74%
50,235
+1,436
+3% +$84.3K
IAU icon
56
iShares Gold Trust
IAU
$62.9B
$3.11M 0.74%
49,863
-280
-0.6% -$17.4K
HYG icon
57
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.56M 0.61%
31,783
-486
-2% -$38.3K
VB icon
58
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$2.37M 0.57%
9,993
-198
-2% -$44.2K
ORCL icon
59
Oracle
ORCL
$374B
$2.16M 0.52%
9,899
-255
-3% -$41.2K
SYK icon
60
Stryker
SYK
$125B
$1.72M 0.41%
4,354
GOOG icon
61
Alphabet (Google) Class C
GOOG
$4.36T
$1.71M 0.41%
9,621
-29
-0.3% -$4.79K
BBH icon
62
VanEck Biotech ETF
BBH
$400M
$1.66M 0.4%
10,812
-499
-4% -$74.3K
JNJ icon
63
Johnson & Johnson
JNJ
$618B
$1.48M 0.35%
9,661
IBB icon
64
iShares Biotechnology ETF
IBB
$9.34B
$1.45M 0.35%
11,465
-462
-4% -$56.7K
CAT icon
65
Caterpillar
CAT
$375B
$1.38M 0.33%
3,542
CVX icon
66
Chevron
CVX
$392B
$1.22M 0.29%
8,520
-88
-1% -$12.4K
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.21M 0.29%
18,069
-994
-5% -$62.9K
VEA icon
68
Vanguard FTSE Developed Markets ETF
VEA
$229B
$1.15M 0.28%
20,216
-778
-4% -$41.7K
PAYX icon
69
Paychex
PAYX
$41.6B
$1.1M 0.26%
7,555
DIA icon
70
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$1.06M 0.25%
2,412
-955
-28% -$396K
IBM icon
71
IBM
IBM
$211B
$947K 0.23%
3,213
HYD icon
72
VanEck High Yield Muni ETF
HYD
$4.43B
$840K 0.2%
16,730
-1,208
-7% -$60.3K
WM icon
73
Waste Management
WM
$90.6B
$707K 0.17%
3,090
VWO icon
74
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$698K 0.17%
14,126
-922
-6% -$42.8K
EMR icon
75
Emerson Electric
EMR
$83.9B
$679K 0.16%
5,100

Similar funds

Boston Research & Management's Q2 2025 Portfolio in Review

As of Q2 2025, Boston Research & Management held 120 positions worth $418M, up 3.9% from $403M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Research & Management's Q2 2025 filing shows 4 new, 36 increased, 38 reduced and 4 closed positions. Its largest new stake was GE Vernova: 600 shares worth $317K. The largest sale was iShares Core S&P 500 ETF, an estimated $480K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q2 2025 buy was GE Vernova: 600 shares worth $317K.
  • Boston Research & Management added most to Thermo Fisher Scientific in Q2 2025, an estimated $685K increase.
  • Boston Research & Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $480K.
  • Boston Research & Management fully exited Yum China in Q2 2025, selling an estimated $224K.
  • Boston Research & Management's ten largest holdings make up 29% of its $418M portfolio in Q2 2025.
  • Boston Research & Management opened 4 new positions and closed 4 in Q2 2025.
  • Boston Research & Management's portfolio value rose 3.9% quarter-over-quarter to $418M.

Based on Boston Research & Management's 13F filing for Q2 2025, filed 12 Aug 2025.